In cell culture models that use a TRF2 dominant negative mutant, Sp1 expression is down-regulated, leading to senescence phenotype [47], thereby highlighting the importance of this transcription factor in telomere biology and reiterating the possibility to target it in cancers that activate telomerase. This evidence concerns the gene SP1 and cancer.